Panacea Biotec is one of India's leading research-based health management companies with established research, manufacturing and marketing capabilities. As a highly progressive and innovative health management company, Panacea Biotec consistently focuses on merging cutting-edge science and technology with its unwavering commitment to spread good health and healthy living. It achieves this end by making novel and innovative medicines within the reach of millions of families across the world, to meet the unmet needs of patients at affordable prices.
The company has collaborations and tie-ups with leading national and international research and commercial organisations and pharmaceutical companies to attain the mutual aim of better-quality healthcare.
Panacea Biotec’s state-of-the-art manufacturing facilities for vaccines and pharmaceutical formulations comply with key International regulatory bodies like USFDA, BfArM Germany, ANVISA Brazil and WHO-cGMP standards.
Panacea Biotec has played a key role in the Global Polio Eradication Initiative by supplying around 10 billion doses of OPV to the Government of India and UN Agencies. This led to reduction in the number of polio cases in India from over 25,000 in 1989 to zero since 2011, thus enabling the country to become a polio-free nation.
Panacea Biotech: Focus on Innovation and R&D
|2013||Ranks among top 25 Biotechnology Companies (ABLE Survey)|
|2006||New Manufacturing facility for pharmaceuticals formulation at Baddi is commissioned|
|2004||Enters into a licensing agreement with National Institute of Health, US, for hair growth hormone|
|1995||Panacea Drugs and Radicura Pharma merges to form Panacea Biotec Ltd|
|1988||Establishes plant for vaccine production at New Delhi under the name Radicura Pharma|
Updated: April, 2014